Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma
- Conditions
- Hepatocellular Carcinoma Non-resectable
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 2
- Registration Number
- NCT03881501
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Tongji-Ezhou Study
Recruiting
- Conditions
- Nutritional and Metabolic DiseasesMetabolic SyndromeRisk Factor, CardiovascularDiabetesCardiovascular DiseasesObesityEnvironmental Exposure
- Interventions
- Other: Dietary and environmental exposure (Observational study)
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2019-02-19
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 10000
- Registration Number
- NCT03845868
- Locations
- 🇨🇳
Huazhong University of Science and Technology, Wuhan, Hubei, China
Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer
Phase 2
Not yet recruiting
- Conditions
- Ovarian Cancer
- Interventions
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 77
- Registration Number
- NCT03818282
Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device
Not Applicable
- Conditions
- Pancreas Neoplasms
- Interventions
- Device: Using 20G FNB, the first pass is SPDevice: Using 22G FNB, the first pass is MWSTDevice: Using 22G FNB, the first pass is SPDevice: Using 20G FNB, the first pass is MWST
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 1224
- Registration Number
- NCT03803930
- Locations
- 🇨🇳
Bin Cheng, Wuhan, Hubei, China
Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
Phase 3
- Conditions
- Gastric Cancer
- Interventions
- Drug: Albumin-bound Paclitaxel plus S-1
- First Posted Date
- 2019-01-11
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 294
- Registration Number
- NCT03801668
- Locations
- 🇨🇳
Tongji hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Efficacy and Safety of Highland Barley Diet on Glucose Variability in Patients With Type 1 Diabetes Mellitus
Not Applicable
Withdrawn
- Conditions
- Type1 Diabetes Mellitus
- Interventions
- Dietary Supplement: Highland Barley Diet
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Huazhong University of Science and Technology
- Registration Number
- NCT03766334
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and technology, Wuhan, Hubei, China
Changes of Regional Tissue Oxygenation Saturation After Successful Femoral Nerve Block
Completed
- Conditions
- Anesthesia, Local
- Interventions
- Device: tissue oxygenation saturation
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2019-05-13
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 100
- Registration Number
- NCT03753594
- Locations
- 🇨🇳
Union Hospital, Wuhan, Hubei, China
Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
Not Applicable
Completed
- Conditions
- Helicobacter Pylori Infection
- Interventions
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 360
- Registration Number
- NCT03688828
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, Hubei, China
Effect-site Concentration of Remifentanil for Double-lumen Tubes Intubation: Airtraq VS Macintosh Laryngoscope
Not Applicable
Completed
- Conditions
- Hemodynamic InstabilityIntubation Complication
- Interventions
- Device: AirtraqDevice: Macintosh
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 62
- Registration Number
- NCT03653910
- Locations
- 🇨🇳
Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China
Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma
Not Applicable
- Conditions
- Hepatocellular Carcinoma by BCLC Stage
- Interventions
- Procedure: anatomical liver resection
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 60
- Registration Number
- NCT03652896
- Locations
- 🇨🇳
Hepatic Surgery Center of Tongji Hospital, Wuhan, Hubei, China
© Copyright 2025. All Rights Reserved by MedPath